These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9630579)
21. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes. Liu YX; Hu ZY; Liu K; Byrne S; Zou RJ; Ny T; d'Lacey C; Ockleford CD Placenta; 1998; 19(2-3):171-80. PubMed ID: 9548184 [TBL] [Abstract][Full Text] [Related]
25. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241 [TBL] [Abstract][Full Text] [Related]
26. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients]. Xiao W; Tong WL; Ma DD Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049 [TBL] [Abstract][Full Text] [Related]
27. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677 [TBL] [Abstract][Full Text] [Related]
28. Effects of retinoids on proliferation and plasminogen activator expression in a bovine mammary epithelial cell line. Cheli F; Politis I; Rossi L; Fusi E; Baldi A J Dairy Res; 2003 Nov; 70(4):367-72. PubMed ID: 14649406 [TBL] [Abstract][Full Text] [Related]
29. Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells. Glass WF; Kreisberg JI; Troyer DA Am J Physiol; 1993 Mar; 264(3 Pt 2):F532-9. PubMed ID: 8384415 [TBL] [Abstract][Full Text] [Related]
30. Cloning of the 5' regulatory regions and functional characterization of the core promoters of ovine PLAU (u-PA) and SERPIN1 (PAI-1). Lampidonis AD; Theodorou G; Pecorini C; Rebucci R; Baldi A; Politis I Gene; 2011 Dec; 489(1):11-20. PubMed ID: 21914465 [TBL] [Abstract][Full Text] [Related]
31. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
32. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process. Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636 [TBL] [Abstract][Full Text] [Related]
33. Leucocyte expression of genes implicated in the plasminogen activation cascade is modulated by yoghurt peptides. Theodorou G; Politis I J Dairy Res; 2016 Aug; 83(3):360-5. PubMed ID: 27600972 [TBL] [Abstract][Full Text] [Related]
34. Regulation and interactions in the activation of cell-associated plasminogen. Myöhänen H; Vaheri A Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213 [TBL] [Abstract][Full Text] [Related]
35. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136 [TBL] [Abstract][Full Text] [Related]
36. Urokinase synthesis and binding by glomerular epithelial cells in culture. Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052 [TBL] [Abstract][Full Text] [Related]
37. The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor. Heegaard CW; Rasmussen LK; Andreasen PA Biochim Biophys Acta; 1994 May; 1222(1):45-55. PubMed ID: 8186264 [TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829 [TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow. McWilliam N; Robbie L; Booth N; Bennett B Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732 [TBL] [Abstract][Full Text] [Related]
40. Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer. Plas E; Carroll VA; Jilch R; Simak R; Mihaly J; Melchior S; Thüroff JW; Binder BR; Pflüger H Cytometry; 2001 Jun; 46(3):184-9. PubMed ID: 11449410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]